{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:09:47Z","timestamp":1760548187414,"version":"3.44.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1053\/j.seminhematol.2004.05.006","type":"journal-article","created":{"date-parts":[[2005,11,3]],"date-time":"2005-11-03T08:58:14Z","timestamp":1131008294000},"page":"246-253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The role of stem cell transplantation in chronic lymphocytic leukemia"],"prefix":"10.1053","volume":"41","author":[{"given":"V","family":"Rizouli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.G","family":"Gribben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2004.05.006_BIB1","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1056\/NEJM199510193331606","article-title":"Chronic lymphocytic leukemia","volume":"333","author":"Rozman","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB2","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/0959-8049(95)00368-1","article-title":"Key issues in the treatment of chronic lymphocytic leukemia","volume":"31A","author":"Catovsky","year":"1995","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB3","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1182\/blood.V94.2.448","article-title":"Clinical characteristics and outcome of young chronic lymphocytic leukemia patients","volume":"94","author":"Mauro","year":"1999","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V46.2.219.219","article-title":"Clinical staging of chronic lymphocytic leukemia","volume":"46","author":"Rai","year":"1975","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB5","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V","article-title":"A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis","volume":"48","author":"Binet","year":"1981","journal-title":"Cancer"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB6","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1182\/blood.V78.6.1545.1545","article-title":"Presenting features and prognosis of chronic lymphocytic leukemia in younger adults","volume":"78","author":"Montserrat","year":"1991","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB7","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1056\/NEJM199009133231105","article-title":"Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities","volume":"323","author":"Juliusson","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB8","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0268-960X(05)80013-X","article-title":"Cytogenetic and molecular abnormalities in chronic lymphocytic leukaemia","volume":"8","author":"Oscier","year":"1994","journal-title":"Blood Rev"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB9","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1365-2141.1996.d01-1478.x","article-title":"Trisomy 12 defines a group of CLL with atypical morphology","volume":"92","author":"Matutes","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB10","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1182\/blood.V69.3.929.929","article-title":"Prognosis of chronic lymphocytic leukemia","volume":"69","author":"Lee","year":"1987","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB11","first-page":"1232","article-title":"Prognostic features and survival in young adults with early\/intermediate chronic lymphocytic leukemia (B-CLL)","volume":"7","author":"Dhodapkar","year":"1993","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB12","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia","volume":"343","author":"Dohner","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB13","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1172\/JCI3009","article-title":"Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors","volume":"102","author":"Fais","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB14","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","article-title":"Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia","volume":"94","author":"Hamblin","year":"1999","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB15","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia","volume":"94","author":"Damle","year":"1999","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB16","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1182\/blood-2002-06-1683","article-title":"Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia","volume":"100","author":"Chen","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB17","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJMoa023143","article-title":"ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia","volume":"348","author":"Crespo","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB18","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1038\/sj.leu.2403147","article-title":"ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia","volume":"17","author":"Durig","year":"2003","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0140-6736(03)15260-9","article-title":"ZAP-70 expression and prognosis in chronic lymphocytic leukaemia","volume":"363","author":"Orchard","year":"2004","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB20","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1182\/blood-2002-10-3306","article-title":"ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile","volume":"101","author":"Wiestner","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB21","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1200\/JCO.1997.15.2.458","article-title":"Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the National Cancer Institute","volume":"15","author":"Sorensen","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/10428190009057630","article-title":"Prediction of prognosis following fludarabine used as secondary therapy for chronic lymphocytic leukemia","volume":"37","author":"Keating","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB23","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1182\/blood.V82.4.1366.1366","article-title":"Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemia","volume":"82","author":"Rabinowe","year":"1993","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB24","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1200\/JCO.1994.12.4.748","article-title":"Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia","volume":"12","author":"Khouri","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.7326\/0003-4819-124-3-199602010-00005","article-title":"HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry","volume":"124","author":"Michallet","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB26","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2141.2000.01900.x","article-title":"Peripheral blood stem cell (PBSC) mobilization and transplantation after fludarabine therapy in chronic lymphocytic leukaemia (CLL)","volume":"108","author":"Michallet","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB27","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1182\/blood.V76.10.2072.2072","article-title":"Detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin hypervariable region specific oligonucleotide probes","volume":"76","author":"Jonsson","year":"1990","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB28","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1182\/blood.V78.11.3021.3021","article-title":"Analysis of B-lymphoid malignancies using allele-specific polymerase chain reaction","volume":"78","author":"Billadeau","year":"1991","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB29","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1182\/blood.V88.6.2228.bloodjournal8862228","article-title":"Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation","volume":"88","author":"Provan","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB30","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.leu.2402036","article-title":"Stem cell transplantation for chronic lymphocytic leukemia","volume":"15","author":"Esteve","year":"2001","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB31","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1200\/JCO.2003.12.011","article-title":"Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation","volume":"21","author":"Schetelig","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB32","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1038\/sj.leu.2401246","article-title":"Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes","volume":"12","author":"Pongers-Willemse","year":"1998","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB33","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1182\/blood.V95.8.2651","article-title":"Immunoglobulin heavy-chain consensus probes for real-time PCR quantification of residual disease in acute lymphoblastic leukemia","volume":"95","author":"Donovan","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1083-8791(00)70006-1","article-title":"Real-time polymerase chain reaction of immunoglobulin rearrangements for quantitative evaluation of minimal residual disease in multiple myeloma","volume":"6","author":"Ladetto","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB35","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1182\/blood.V86.8.3257.3257","article-title":"Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma","volume":"86","author":"Bastion","year":"1995","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB36","first-page":"149","article-title":"High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin\u2019s lymphoma","volume":"17","author":"Haas","year":"1996","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB37","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1600-0609.1998.tb01055.x","article-title":"Evaluation of marrow and blood haemopoietic progenitors in chronic lymphocytic leukaemia before and after chemotherapy","volume":"61","author":"Sala","year":"1998","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB38","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1182\/blood-2003-05-1449","article-title":"Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia","volume":"103","author":"Tournilhac","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB39","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1365-2257.1999.00179.x","article-title":"Factors influencing platelet recovery after autologous transplantation of G-CSF-mobilized peripheral blood stem\/progenitor cells following myeloablative therapy in 50 heavily pretreated lymphoma patients","volume":"21","author":"Hassan","year":"1999","journal-title":"Clin Lab Haematol"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB40","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1038\/sj.leu.2401201","article-title":"Autologous hematopoietic stem cell transplantation as salvage treatment for advanced B cell chronic lymphocytic leukemia","volume":"12","author":"Sutton","year":"1998","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB41","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/sj.leu.2403190","article-title":"Successful CD34+ cell mobilization by intermediate-dose Ara-C in chronic lymphocytic leukemia patients treated with sequential fludarabine and Campath-1H","volume":"18","author":"Montillo","year":"2004","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB42","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJM198706113162401","article-title":"High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin\u2019s lymphoma","volume":"316","author":"Philip","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB43","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/sj.bmt.1700730","article-title":"Autologous blood cell transplantation in B-CLL","volume":"19","author":"Itala","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB44","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1023\/A:1008474526373","article-title":"High incidence of relapse after autologous stem-cell transplantation for B-cell chronic lymphocytic leukemia or small lymphocytic lymphoma","volume":"9","author":"Pavletic","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB45","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1038\/bjc.1998.381","article-title":"Early stem cell transplantation for chronic lymphocytic leukaemia","volume":"77","author":"Dreger","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB46","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1023\/A:1008266505896","article-title":"Hematopoietic stem cell transplantation in chronic lymphocytic leukemia","volume":"9","author":"Esteve","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB47","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/sj.bmt.1702026","article-title":"Dose intensification and molecular responses in patients with chronic lymphocytic leukaemia","volume":"24","author":"Schey","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB48","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-2249.1992.tb06965.x","article-title":"Predictors of infection in chronic lymphocytic leukaemia (CLL)","volume":"89","author":"Griffiths","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB49","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1182\/blood.V80.1.29.29","article-title":"Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone","volume":"80","author":"Robertson","year":"1993","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB50","first-page":"799","article-title":"Unusual infections following allogeneic bone marrow transplantation for chronic lymphocytic leukemia","volume":"14","author":"Zomas","year":"1994","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB51","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/10428199709109161","article-title":"Antimicrobial prophylaxis to prevent opportunistic infections in patients with chronic lymphocytic leukemia after allogeneic blood or marrow transplantation","volume":"26","author":"Mehta","year":"1997","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB52","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1046\/j.1365-2141.1997.272673.x","article-title":"Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia","volume":"97","author":"Khouri","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB53","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/sj.bmt.1703548","article-title":"Allogeneic related donor hematopoietic stem cell transplantation for treatment of chronic lymphocytic leukemia","volume":"29","author":"Doney","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB54","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/146532402320219736","article-title":"Long-term follow-up of patients with CLL treated with allogeneic hematopoietic transplantation","volume":"4","author":"Khouri","year":"2002","journal-title":"Cytotherapy"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB55","first-page":"669","article-title":"Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemia","volume":"18","author":"Rondon","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB56","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/sj.bmt.1700850","article-title":"Induction of graft-versus-leukemia effect in a patient with chronic lymphocytic leukemia","volume":"20","author":"deMagalhaes-Silverman","year":"1997","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB57","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1200\/JCO.1998.16.8.2817","article-title":"Transplant-lite","volume":"16","author":"Khouri","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB58","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1182\/blood.V98.13.3595","article-title":"Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma","volume":"98","author":"Khouri","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB59","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.exphem.2003.09.021","article-title":"Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia","volume":"32","author":"Khouri","year":"2004","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB60","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/sj.bmt.1701127","article-title":"Treatment of T prolymphocytic leukemia with allogeneic bone marrow transplantation","volume":"21","author":"Collins","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB61","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1182\/blood.V98.6.1721","article-title":"High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H","volume":"98","author":"Dearden","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB62","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1182\/blood.V81.11.2878.2878","article-title":"Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent","volume":"81","author":"Keating","year":"1993","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB63","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3109\/10428199209067613","article-title":"Salvage therapy with fludarabine in patients with progressive B-chronic lymphocytic leukemia","volume":"21","author":"Gjedde","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB64","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/S0140-6736(96)91681-5","article-title":"Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL","volume":"347","author":"Johnson","year":"1996","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2004.05.006_BIB65","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1182\/blood.V85.2.307.307","article-title":"Advances in the biology and treatment of B-cell chronic lymphocytic leukemia","volume":"85","author":"O\u2019Brien","year":"1995","journal-title":"Blood"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196304000939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196304000939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:15:42Z","timestamp":1758521742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196304000939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S0037196304000939"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2004.05.006","relation":{},"ISSN":["0037-1963"],"issn-type":[{"type":"print","value":"0037-1963"}],"subject":[],"published":{"date-parts":[[2004,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of stem cell transplantation in chronic lymphocytic leukemia","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2004.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}